With our N-NOSE® nematode cancer test, inspectors have manually performed part of the inspection process until now. This time, we have succeeded in fully automating all inspection and analysis processes. We plan to mass-produce this automatic analysis machine, and build a robust system to realize more than 1 million samples annually.
TOKYO, JAPAN – March 6, 2026 – HIROTSU Bio Science Inc. announced the establishment of a new U.S. subsidiary, Hirotsu Global Inc., effectively c . . .
2026.03.06FOR IMMEDIATE RELEASE HIROTSU Bio Science Announces Referral of Former Employee to Prosecutors for Violation of the Unfair Competition Preven . . .
2026.02.05A novel, non-invasive approach to detecting micro-distant metastasis in highly lethal pancreatic cancer. TOKYO, JAPAN – January 5, 2026 – HIR . . .
2026.01.05